Sam Dajani is the interim Chief Executive Officer of Vela Diagnostics. He is currently responsible for the overall operation of Luye Diagnostics (Intl.), covering Vela Diagnostics (Intl.) and Great Basin Scientific (Intl.).
Sam has over 30 years of management, strategic and operational experience in the Biotechnology, Speciality Chemicals and Pharmaceutical industry. Before joining Vela Diagnostics as Chief Executive Officer (CEO), he held senior positions at several multi-national companies such as Director of Sales and Marketing at Pfizer Inc., General Manager at Kaneka Corporation, President of Danaher Corporation (APAC), Global Chief Operating Officer (COO) at Cathay Industrial Biotech Ltd., and Global Chief Executive Officer (CEO) at Cyklop International.